Immunodeficiency Flashcards

1
Q

Which immunodeficiency in common? primary or secondary?

A

Secondary immunodeficiency (due to disease or medication)

(It is encountered by physician on a daily basis in routine practice)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the pattern of infection in immunodeficiency?

A
  • Neutrophil defects
  • Complement deficiency
  • B cell/antibody deficiency
  • T cell deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Primary Immunodeficiency: Classification >> Major categories

A
  • Neutrophil disorders/deficiencies
  • Complement deficiencies
  • B cell/antibody disorders/deficiencies
  • T cell disorders/deficiencies
  • Combined B & T cell disorders/deficiencies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Primary immunodeficiency: Neutrophil defects

A

Mnemonic ‘CCL’

  • Chronic granulomatous disease
  • Chediak-higashi syndrome
  • Leukocyte adhesion deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Primary immunodeficiency: complement defects

A

The most importants are >>

  • C1q deficiency
  • C1INH deficiency
  • Final common pathway defects
  • & many others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Primary immunodeficiency: B cell/Antibody disorders

A

​Mnemonic ABC

  • IgA** deficiency**
  • Bruton’s congenital agammaglobulinaemia
  • Common variable immunodeficiency (CVID)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Primary immunodeficiency: T-cell defects

A

DiGeorge syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Secondary immunodeficiency >> Example by categories

A
  • Neutrophil defect:
    • Diabetes mellitus
  • Complement deficiency:
    • Eculizumab therapy
  • B cell/ Antibody defect:
    • Chronic lymphocytic leukaemia (CLL)
    • Rituximab
    • Phenytoin
    • Gold
  • T-cell defect:
    • HIV infection
    • Ciclosporin
    • Anti-CD3 therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Primary immunodeficiency: Combined B and T cell defects

A

Mnemonic: SCID WAS Ataxic

  • SCID (Severe combined Immunodeficiency)
  • Ataxia Telangiectasia
  • Wiskott-Aldrich syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Neutrophil defects are associated with-?

A

Recurrent bacterial or fungal skin infection (Cellulitis/Abscess)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Neutrophil defects: Examples

A
  • Primary: CCL
    • Chronic granulomatous disease
    • Chediak-higashi syndrome
    • Leukocyte adhesion deficiency
  • Secondary: Diabetes mellitus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Complement deficiency: identification

A

It may be uncovered incidentally (as NOT always symptomatic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The most important clinical association with complement deficiency-?

A
  • Hereditary angioedema (C1-inhibitor deficiency)
  • SLE (C1q deficiency)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does happen if there is “final common pathway” defect?

A

Recurrent/invasive Neisseria spp. infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Complement deficiency: Examples

A
  • Primary:
    • C1q deficiency
    • C1-INH deficiency
    • ‘final common pathway’ deficiencies
  • Secondary: Eculizumab treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Eculizumab >> mechanism

A

C5 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Eculizumab >> Indication

A

PNH (Paroxysmal nocturanl haemoglobinuria)

(Its a complement mediated RBC cell lysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Eculizumab: Main side-effect

A

Secondary complement deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

B-cell/antibody deficiency >> results in??

A
  • Sinopulmonary infections
  • Bronchiectasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

B-cell/antibody deficiency: Examples

A
  • Primary ABC
    • Selective IgA deficiency
    • Bruton’s agammaglobulinemia
    • ​Common variable immunodeficiency
  • ​Secondary
    • ​Chronic lymphocytic leukaemia (CLL)
    • Rituximab
    • Gold
    • Phenytoin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Chronic Granulomatous Disease: Inheritance

A

Variable pattern of penetrance

Mainly X-linked recessive

22
Q

Which is more common between IgA deficiency and IgG2 deficiency?

A

Primary IgA deficieny is more common than IgG2 deficiency in population

23
Q

IgA deficiency: main pathophysiology

A

Maturation defect of B cell

24
Q

IgA deficiency: Features

A

NO sign-symptoms

can cause bronchiectasis

25
**Time period of \>\>** **Bruton's congenital agammaglobulinaemia** **Common variable immunodeficiency (CVID)**
* **Bruton's agammaglobulinaemia: within 1st 18months** * **CVID: late teenage**
26
**Bruton's congenital agammaglobulinaemia: Inheritance**
**X-linked recessive**
27
**Bruton's congenital agammaglobulinaemia: pathophysiology**
* **Mutation in Bruton's kinase** * **Defective maturation of B cell ( = NO/less formation of plasma cells = less Ig production)** * **Immunoglobulin (Ig) deficiency**
28
**Common variable immunodeficiency (CVID): manifestations**
* **Impaired function of antibody response \>\>\> recurrent sino-pulmonary infections** * **2 or more Ig are reduced among \>\>\> IgA, IgM, IgG** * **More common: IgA reduction** * **More reduced: IgG** (than IgM)​ * ​**No sign-symptoms**
29
**T-cell deficiency \>\> results in-?**
**The following opportunistic infections** * **Pneumocystis jirovecii** * **Invasive virus (e.g. CMV: Cytomegalovirus)** * **Intracellular bacteria (e.g. Salmonella)** * **Mycobacteria**
30
**T-cell deficiency: Examples**
* **Primary** * **​DiGeorge syndrome** * **​Secondary** * **​HIV infection** * **Cyclosporin** * **Anti-CD3 therapy** * **​Combined B + T cell deficiencies (primary)** *Mnemonic: SCID WAS Ataxic* * **Severe combined immunodeficiency (SCID)** * **Wiskott-Aldrich syndrome** * **Ataxia telangiectasia**
31
**DiGeorge syndrome \>\> type of genetic disorder**
**Microdeletion syndrome**
32
**DiGeorge syndrome: type of infections**
**Viral and fungal infections** (high risk) (As it is a T-cell defect)
33
**DiGeorge syndrome: genetic defect**
**Chromosome 22 deletion (chromosome 22q11 anomaly)**
34
**DiGeorge syndrome: Features**
*Above downwards* * **Learning disabilities** * **Hypertelorism (increased distance between 2 orbits)** * **Abnormal ear** * **Cleft palate, short philtrum** * **Micrognathia** * **Maldevelopment of pharyngeal pouch** * **NO parathyroid development \>\>\> hypocalcaemia \>\>\> tetany** * **NO development of normal thymus** * **Normal B cell (rests are low)** * **Reduced T cell production** * **Reduced _IgG_ response** * **Reduced _IgA_ response** * **Congenital heart disease** * **Defect in great vessels** * **Hypocalcaemia (low calcium level)**
35
**Combined B-cell and T-cell disorder: Inheritance**
* **Severe combined Immunodeficiency (SCID): X-linked recessive** * **Wiskott-Aldrich syndrome: X-linked recessive** * **Ataxia telangiectasia: Autosomal recessive**
36
**SCID (Severe combined Immunodeficiency): Enzyme defect**
**Reduced ADA (Adenosine deaminase) enzyme**
37
**SCID (Severe combined Immunodeficiency): Pathophysiology**
**ADA (Adenosine deaminase enzyme) normally converts \>\>\>** * **Deoxyadenosine to deoxynosine (AND, also)** * **Adenosine to inosine** **​In SCID \>\>\> reduced ADA \>\>\>** **so,** * **High deoxyadenosine, low inosine etc.** **​\>\>\> deoxyadenosine is toxic to lymphocytes (both B and T cells) [especially immature T cells of thymus]**
38
**Wiskott Aldrich Syndrome: gender ratio**
**Mainly male (as X-linked recessive)**
39
**Type of Immunoglobulin deficiency in Wiskott-Aldrich syndrome and Ataxia telangiectasia**
* **Wiskott-Aldrich syndrome \>\>\> IgG, IgM deficiency** * **Ataxia telangiectasia \>\>\> IgA deficiency**
40
**Wiskott Aldrich syndrome and Ataxia telagiectasia: Common features**
* **Recurrent chect infections** * **Haematological malignancy (lymphoma, leukaemia, non-lymphoid tumours)** * **Melignancy**
41
**Wiskott Aldrich syndrome: genetic defect**
**mutation in "WASP" gene**
42
**Wiskott Aldrich syndrome: Features**
* **Thrombocytopaenia** * **Low IgG, Low IgM** * **Humoral immunodeficiency** * **Recurrent chect infections** * **Severe bacterial infection** * **Eczema** * **Autoimmunity** * **Malignancy** * **Haematological cancer (leukaemia, lymphoma etc.)**
43
**Wiskott Aldrich syndrome: Life expectancy**
**6 to 30years**
44
**Wiskott Aldrich syndrome: Main cause of death**
**Bleeding** (maybe due to thrombocytopaenia)
45
**Ataxia telangiectasia: Features**
* **10% risk of developing maligancy** * **Lymphoma** * **Leukaemia** * **Non-lymphoid tumours** * **Recurrent chest infections** * **Low IgA**
46
**Job syndrome \>\> Another name?**
**Hyper-IgE syndrome**
47
**Job syndrome is named after whom?**
**It is named after Job in the Bible** **who was plaged with boils**
48
**Job syndrome: pathophysiology**
**Failure of intracellular signalling in JAK-STAT pathway \>\>\> Multiple immune failures \>\>\> both: innate & adaptive responses**
49
**Job syndrome: Clinical features**
Mnemonic: *FATED* * **F**acies: Coarse or leonine * **A**bscess: Cold abscess by staphylococcus spp. * **T**eeth: Retention of primary teeth * **E**: High Ig**E** * **D**ermatological problems: Eczema **Manifestations are heterogenous ​** **It is one of the very few diseases that is associated with \>\>\> Cryptococcus pneumonia (Cryptococcus neoformans)**
50
**Job syndrome: 2 main organisms & their manifestations**
* **Staphylococcus spp. \>\>\> cold abscess** * **Cryptococcus neoformans \>\>\> Cryptococcal pneumonia**
51
**Why is Job syndrome important regarding pathophysiology?**
It has **failue in 'intracellular signalling'** in the **JAK-STAT pathway** **& JAK-STAT pathway** has been earmarked as the **next major immune pathway to inibit** in the treatment of **autoimmune diseases**
52
**JAK inhibitor \>\> Indication**
**Cryptococcal pneumonia** FDA licensed the first JAK inhibitor in 2012